BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li DD, Tang YL, Wang X. Challenges and exploration for immunotherapies targeting cold colorectal cancer. World J Gastrointest Oncol 2023; 15(1): 55-68 [PMID: 36684057 DOI: 10.4251/wjgo.v15.i1.55]
URL: https://www.wjgnet.com/1948-5204/full/v15/i1/55.htm
Number Citing Articles
1
Takehiko Yokobori. Editorial Comment on: The Impact of Programmed Death-Ligand 1 Expression on Mismatch Repair Deficiency and Epstein–Barr Virus Status on Survival Outcomes in Patients with Stage II/III Gastric Cancer After SurgeryAnnals of Surgical Oncology 2023; 30(11): 6306 doi: 10.1245/s10434-023-13761-4
2
Aitoshi Hoshimoto, Atsushi Tatsuguchi, Ryohei Hamakubo, Takayoshi Nishimoto, Jun Omori, Naohiko Akimoto, Shu Tanaka, Shunji Fujimori, Tsutomu Hatori, Akira Shimizu, Katsuhiko Iwakiri. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironmentWorld Journal of Gastroenterology 2023; 29(40): 5566-5581 doi: 10.3748/wjg.v29.i40.5566
3
Brindley Hapuarachi, Sarah Danson, Jon Wadsley, Munitta Muthana. Exercise to transform tumours from cold to hot and improve immunotherapy responsivenessFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1335256
4
Gholam‐Reza Khosravi, Samaneh Mostafavi, Sanaz Bastan, Narges Ebrahimi, Roya Safari Gharibvand, Nahid Eskandari. Immunologic tumor microenvironment modulators for turning cold tumors hotCancer Communications 2024;  doi: 10.1002/cac2.12539